Studies have shown that upregulation of MAGI2-AS3 promotes Aβ deposition and inflammation, leading to speculation that MAGI2-AS3 may be related to the neuroinflammatory response in AD. The gene discussed is PDS5B; the disease is Alzheimer disease.